Soundbar
The research report includes specific segments by region (country), by company, by Type and by Ap ... Read More
Global Nanopharmaceuticals Market Outlook 2023
1 Nanopharmaceuticals Market Overview
1.1 Product Overview and Scope of Nanopharmaceuticals
1.2 Nanopharmaceuticals Segment by Type
1.2.1 Global Nanopharmaceuticals Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Liposomes
1.2.3 Polymeric Micelles
1.2.4 Solid Lipid Nanoparticles
1.2.5 Microemulsion and Nnanoemulsion
1.2.6 Nanosuspension
1.3 Nanopharmaceuticals Segment by Application
1.3.1 Global Nanopharmaceuticals Sales Comparison by Application: (2021-2027)
1.3.2 Cancer and Tumor
1.3.3 Autoimmune Disorders
1.3.4 Inflammation
1.3.5 Others
1.4 Global Nanopharmaceuticals Market Size Estimates and Forecasts
1.4.1 Global Nanopharmaceuticals Revenue 2016-2027
1.4.2 Global Nanopharmaceuticals Sales 2016-2027
1.4.3 Nanopharmaceuticals Market Size by Region: 2016 Versus 2021 Versus 2027
2 Nanopharmaceuticals Market Competition by Manufacturers
2.1 Global Nanopharmaceuticals Sales Market Share by Manufacturers (2016-2021)
2.2 Global Nanopharmaceuticals Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Nanopharmaceuticals Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Nanopharmaceuticals Manufacturing Sites, Area Served, Product Type
2.5 Nanopharmaceuticals Market Competitive Situation and Trends
2.5.1 Nanopharmaceuticals Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Nanopharmaceuticals Players Market Share by Revenue
2.5.3 Global Nanopharmaceuticals Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Nanopharmaceuticals Retrospective Market Scenario by Region
3.1 Global Nanopharmaceuticals Retrospective Market Scenario in Sales by Region: 2016-2021
3.2 Global Nanopharmaceuticals Retrospective Market Scenario in Revenue by Region: 2016-2021
3.3 North America Nanopharmaceuticals Market Facts & Figures by Country
3.3.1 North America Nanopharmaceuticals Sales by Country
3.3.2 North America Nanopharmaceuticals Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Nanopharmaceuticals Market Facts & Figures by Country
3.4.1 Europe Nanopharmaceuticals Sales by Country
3.4.2 Europe Nanopharmaceuticals Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Nanopharmaceuticals Market Facts & Figures by Region
3.5.1 Asia Pacific Nanopharmaceuticals Sales by Region
3.5.2 Asia Pacific Nanopharmaceuticals Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Nanopharmaceuticals Market Facts & Figures by Country
3.6.1 Latin America Nanopharmaceuticals Sales by Country
3.6.2 Latin America Nanopharmaceuticals Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Nanopharmaceuticals Market Facts & Figures by Country
3.7.1 Middle East and Africa Nanopharmaceuticals Sales by Country
3.7.2 Middle East and Africa Nanopharmaceuticals Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Nanopharmaceuticals Historic Market Analysis by Type
4.1 Global Nanopharmaceuticals Sales Market Share by Type (2016-2021)
4.2 Global Nanopharmaceuticals Revenue Market Share by Type (2016-2021)
4.3 Global Nanopharmaceuticals Price by Type (2016-2021)
5 Global Nanopharmaceuticals Historic Market Analysis by Application
5.1 Global Nanopharmaceuticals Sales Market Share by Application (2016-2021)
5.2 Global Nanopharmaceuticals Revenue Market Share by Application (2016-2021)
5.3 Global Nanopharmaceuticals Price by Application (2016-2021)
6 Key Companies Profiled
6.1 Merck
6.1.1 Merck Corporation Information
6.1.2 Merck Description and Business Overview
6.1.3 Merck Nanopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Merck Nanopharmaceuticals Product Portfolio
6.1.5 Merck Recent Developments/Updates
6.2 Pfizer
6.2.1 Pfizer Corporation Information
6.2.2 Pfizer Description and Business Overview
6.2.3 Pfizer Nanopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Pfizer Nanopharmaceuticals Product Portfolio
6.2.5 Pfizer Recent Developments/Updates
6.3 Novartis
6.3.1 Novartis Corporation Information
6.3.2 Novartis Description and Business Overview
6.3.3 Novartis Nanopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Novartis Nanopharmaceuticals Product Portfolio
6.3.5 Novartis Recent Developments/Updates
6.4 Abbott
6.4.1 Abbott Corporation Information
6.4.2 Abbott Description and Business Overview
6.4.3 Abbott Nanopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Abbott Nanopharmaceuticals Product Portfolio
6.4.5 Abbott Recent Developments/Updates
6.5 GlaxoSmithKline
6.5.1 GlaxoSmithKline Corporation Information
6.5.2 GlaxoSmithKline Description and Business Overview
6.5.3 GlaxoSmithKline Nanopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
6.5.4 GlaxoSmithKline Nanopharmaceuticals Product Portfolio
6.5.5 GlaxoSmithKline Recent Developments/Updates
6.6 Roche
6.6.1 Roche Corporation Information
6.6.2 Roche Description and Business Overview
6.6.3 Roche Nanopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Roche Nanopharmaceuticals Product Portfolio
6.6.5 Roche Recent Developments/Updates
6.7 Sanofi
6.6.1 Sanofi Corporation Information
6.6.2 Sanofi Description and Business Overview
6.6.3 Sanofi Nanopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Sanofi Nanopharmaceuticals Product Portfolio
6.7.5 Sanofi Recent Developments/Updates
6.8 Eli Lilly
6.8.1 Eli Lilly Corporation Information
6.8.2 Eli Lilly Description and Business Overview
6.8.3 Eli Lilly Nanopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Eli Lilly Nanopharmaceuticals Product Portfolio
6.8.5 Eli Lilly Recent Developments/Updates
6.9 Astrazeneca
6.9.1 Astrazeneca Corporation Information
6.9.2 Astrazeneca Description and Business Overview
6.9.3 Astrazeneca Nanopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
6.9.4 Astrazeneca Nanopharmaceuticals Product Portfolio
6.9.5 Astrazeneca Recent Developments/Updates
6.10 Johnson & Johnson
6.10.1 Johnson & Johnson Corporation Information
6.10.2 Johnson & Johnson Description and Business Overview
6.10.3 Johnson & Johnson Nanopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
6.10.4 Johnson & Johnson Nanopharmaceuticals Product Portfolio
6.10.5 Johnson & Johnson Recent Developments/Updates
6.11 Celgene
6.11.1 Celgene Corporation Information
6.11.2 Celgene Nanopharmaceuticals Description and Business Overview
6.11.3 Celgene Nanopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
6.11.4 Celgene Nanopharmaceuticals Product Portfolio
6.11.5 Celgene Recent Developments/Updates
6.12 Novavax
6.12.1 Novavax Corporation Information
6.12.2 Novavax Nanopharmaceuticals Description and Business Overview
6.12.3 Novavax Nanopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
6.12.4 Novavax Nanopharmaceuticals Product Portfolio
6.12.5 Novavax Recent Developments/Updates
6.13 Stryker
6.13.1 Stryker Corporation Information
6.13.2 Stryker Nanopharmaceuticals Description and Business Overview
6.13.3 Stryker Nanopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
6.13.4 Stryker Nanopharmaceuticals Product Portfolio
6.13.5 Stryker Recent Developments/Updates
6.14 Gilead Sciences
6.14.1 Gilead Sciences Corporation Information
6.14.2 Gilead Sciences Nanopharmaceuticals Description and Business Overview
6.14.3 Gilead Sciences Nanopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
6.14.4 Gilead Sciences Nanopharmaceuticals Product Portfolio
6.14.5 Gilead Sciences Recent Developments/Updates
6.15 OSI Pharmaceuticals
6.15.1 OSI Pharmaceuticals Corporation Information
6.15.2 OSI Pharmaceuticals Nanopharmaceuticals Description and Business Overview
6.15.3 OSI Pharmaceuticals Nanopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
6.15.4 OSI Pharmaceuticals Nanopharmaceuticals Product Portfolio
6.15.5 OSI Pharmaceuticals Recent Developments/Updates
6.16 Kadmon Pharmaceuticals
6.16.1 Kadmon Pharmaceuticals Corporation Information
6.16.2 Kadmon Pharmaceuticals Nanopharmaceuticals Description and Business Overview
6.16.3 Kadmon Pharmaceuticals Nanopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
6.16.4 Kadmon Pharmaceuticals Nanopharmaceuticals Product Portfolio
6.16.5 Kadmon Pharmaceuticals Recent Developments/Updates
6.17 Samyang Biopharm
6.17.1 Samyang Biopharm Corporation Information
6.17.2 Samyang Biopharm Nanopharmaceuticals Description and Business Overview
6.17.3 Samyang Biopharm Nanopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
6.17.4 Samyang Biopharm Nanopharmaceuticals Product Portfolio
6.17.5 Samyang Biopharm Recent Developments/Updates
6.18 Mitsubishi Pharma
6.18.1 Mitsubishi Pharma Corporation Information
6.18.2 Mitsubishi Pharma Nanopharmaceuticals Description and Business Overview
6.18.3 Mitsubishi Pharma Nanopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
6.18.4 Mitsubishi Pharma Nanopharmaceuticals Product Portfolio
6.18.5 Mitsubishi Pharma Recent Developments/Updates
6.19 Kaken Pharmaceutical
6.19.1 Kaken Pharmaceutical Corporation Information
6.19.2 Kaken Pharmaceutical Nanopharmaceuticals Description and Business Overview
6.19.3 Kaken Pharmaceutical Nanopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
6.19.4 Kaken Pharmaceutical Nanopharmaceuticals Product Portfolio
6.19.5 Kaken Pharmaceutical Recent Developments/Updates
6.20 Selecta Biosciences
6.20.1 Selecta Biosciences Corporation Information
6.20.2 Selecta Biosciences Nanopharmaceuticals Description and Business Overview
6.20.3 Selecta Biosciences Nanopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
6.20.4 Selecta Biosciences Nanopharmaceuticals Product Portfolio
6.20.5 Selecta Biosciences Recent Developments/Updates
6.21 Par Pharmaceutical
6.21.1 Par Pharmaceutical Corporation Information
6.21.2 Par Pharmaceutical Nanopharmaceuticals Description and Business Overview
6.21.3 Par Pharmaceutical Nanopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
6.21.4 Par Pharmaceutical Nanopharmaceuticals Product Portfolio
6.21.5 Par Pharmaceutical Recent Developments/Updates
6.22 Cerulean Pharma
6.22.1 Cerulean Pharma Corporation Information
6.22.2 Cerulean Pharma Nanopharmaceuticals Description and Business Overview
6.22.3 Cerulean Pharma Nanopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
6.22.4 Cerulean Pharma Nanopharmaceuticals Product Portfolio
6.22.5 Cerulean Pharma Recent Developments/Updates
6.23 Navidea Biopharmaceuticals
6.23.1 Navidea Biopharmaceuticals Corporation Information
6.23.2 Navidea Biopharmaceuticals Nanopharmaceuticals Description and Business Overview
6.23.3 Navidea Biopharmaceuticals Nanopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
6.23.4 Navidea Biopharmaceuticals Nanopharmaceuticals Product Portfolio
6.23.5 Navidea Biopharmaceuticals Recent Developments/Updates
6.24 Lummy
6.24.1 Lummy Corporation Information
6.24.2 Lummy Nanopharmaceuticals Description and Business Overview
6.24.3 Lummy Nanopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
6.24.4 Lummy Nanopharmaceuticals Product Portfolio
6.24.5 Lummy Recent Developments/Updates
7 Nanopharmaceuticals Manufacturing Cost Analysis
7.1 Nanopharmaceuticals Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Nanopharmaceuticals
7.4 Nanopharmaceuticals Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Nanopharmaceuticals Distributors List
8.3 Nanopharmaceuticals Customers
9 Nanopharmaceuticals Market Dynamics
9.1 Nanopharmaceuticals Industry Trends
9.2 Nanopharmaceuticals Growth Drivers
9.3 Nanopharmaceuticals Market Challenges
9.4 Nanopharmaceuticals Market Restraints
10 Global Market Forecast
10.1 Nanopharmaceuticals Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Nanopharmaceuticals by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Nanopharmaceuticals by Type (2022-2027)
10.2 Nanopharmaceuticals Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Nanopharmaceuticals by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Nanopharmaceuticals by Application (2022-2027)
10.3 Nanopharmaceuticals Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Nanopharmaceuticals by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Nanopharmaceuticals by Region (2022-2027)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Nanopharmaceuticals Sales (K MT) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Nanopharmaceuticals Sales (K MT) Comparison by Application (2021-2027)
Table 3. Global Nanopharmaceuticals Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Nanopharmaceuticals Covered in This Study
Table 5. Global Nanopharmaceuticals Sales (K MT) of Key Manufacturers (2016-2021)
Table 6. Global Nanopharmaceuticals Sales Market Share by Manufacturers (2016-2021)
Table 7. Global Nanopharmaceuticals Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Nanopharmaceuticals Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Nanopharmaceuticals Average Price (USD/MT) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Nanopharmaceuticals Manufacturing Sites and Area Served
Table 11. Manufacturers Nanopharmaceuticals Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Nanopharmaceuticals by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Nanopharmaceuticals as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Nanopharmaceuticals Sales by Region (2016-2021) & (K MT)
Table 16. Global Nanopharmaceuticals Sales Market Share by Region (2016-2021)
Table 17. Global Nanopharmaceuticals Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Nanopharmaceuticals Sales by Country (2016-2021) & (K MT)
Table 19. North America Nanopharmaceuticals Sales Market Share by Country (2016-2021)
Table 20. North America Nanopharmaceuticals Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Nanopharmaceuticals Revenue Market Share by Country (2016-2021)
Table 22. Europe Nanopharmaceuticals Sales by Country (2016-2021) & (K MT)
Table 23. Europe Nanopharmaceuticals Sales Market Share by Country (2016-2021)
Table 24. Europe Nanopharmaceuticals Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Nanopharmaceuticals Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Nanopharmaceuticals Sales by Region (2016-2021) & (K MT)
Table 27. Asia Pacific Nanopharmaceuticals Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Nanopharmaceuticals Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Nanopharmaceuticals Revenue Market Share by Region (2016-2021)
Table 30. Latin America Nanopharmaceuticals Sales by Country (2016-2021) & (K MT)
Table 31. Latin America Nanopharmaceuticals Sales Market Share by Country (2016-2021)
Table 32. Latin America Nanopharmaceuticals Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Nanopharmaceuticals Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Nanopharmaceuticals Sales by Country (2016-2021) & (K MT)
Table 35. Middle East and Africa Nanopharmaceuticals Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Nanopharmaceuticals Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Nanopharmaceuticals Revenue Market Share by Country (2016-2021)
Table 38. Global Nanopharmaceuticals Sales (K MT) by Type (2016-2021)
Table 39. Global Nanopharmaceuticals Sales Market Share by Type (2016-2021)
Table 40. Global Nanopharmaceuticals Revenue (Million US$) by Type (2016-2021)
Table 41. Global Nanopharmaceuticals Revenue Share by Type (2016-2021)
Table 42. Global Nanopharmaceuticals Price (USD/MT) by Type (2016-2021)
Table 43. Global Nanopharmaceuticals Sales (K MT) by Application (2016-2021)
Table 44. Global Nanopharmaceuticals Sales Market Share by Application (2016-2021)
Table 45. Global Nanopharmaceuticals Revenue (Million US$) by Application (2016-2021)
Table 46. Global Nanopharmaceuticals Revenue Share by Application (2016-2021)
Table 47. Global Nanopharmaceuticals Price (USD/MT) by Application (2016-2021)
Table 48. Merck Corporation Information
Table 49. Merck Description and Business Overview
Table 50. Merck Nanopharmaceuticals Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 51. Merck Nanopharmaceuticals Product
Table 52. Merck Recent Developments/Updates
Table 53. Pfizer Corporation Information
Table 54. Pfizer Description and Business Overview
Table 55. Pfizer Nanopharmaceuticals Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 56. Pfizer Nanopharmaceuticals Product
Table 57. Pfizer Recent Developments/Updates
Table 58. Novartis Corporation Information
Table 59. Novartis Description and Business Overview
Table 60. Novartis Nanopharmaceuticals Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 61. Novartis Nanopharmaceuticals Product
Table 62. Novartis Recent Developments/Updates
Table 63. Abbott Corporation Information
Table 64. Abbott Description and Business Overview
Table 65. Abbott Nanopharmaceuticals Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 66. Abbott Nanopharmaceuticals Product
Table 67. Abbott Recent Developments/Updates
Table 68. GlaxoSmithKline Corporation Information
Table 69. GlaxoSmithKline Description and Business Overview
Table 70. GlaxoSmithKline Nanopharmaceuticals Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 71. GlaxoSmithKline Nanopharmaceuticals Product
Table 72. GlaxoSmithKline Recent Developments/Updates
Table 73. Roche Corporation Information
Table 74. Roche Description and Business Overview
Table 75. Roche Nanopharmaceuticals Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 76. Roche Nanopharmaceuticals Product
Table 77. Roche Recent Developments/Updates
Table 78. Sanofi Corporation Information
Table 79. Sanofi Description and Business Overview
Table 80. Sanofi Nanopharmaceuticals Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 81. Sanofi Nanopharmaceuticals Product
Table 82. Sanofi Recent Developments/Updates
Table 83. Eli Lilly Corporation Information
Table 84. Eli Lilly Description and Business Overview
Table 85. Eli Lilly Nanopharmaceuticals Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 86. Eli Lilly Nanopharmaceuticals Product
Table 87. Eli Lilly Recent Developments/Updates
Table 88. Astrazeneca Corporation Information
Table 89. Astrazeneca Description and Business Overview
Table 90. Astrazeneca Nanopharmaceuticals Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 91. Astrazeneca Nanopharmaceuticals Product
Table 92. Astrazeneca Recent Developments/Updates
Table 93. Johnson & Johnson Corporation Information
Table 94. Johnson & Johnson Description and Business Overview
Table 95. Johnson & Johnson Nanopharmaceuticals Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 96. Johnson & Johnson Nanopharmaceuticals Product
Table 97. Johnson & Johnson Recent Developments/Updates
Table 98. Celgene Corporation Information
Table 99. Celgene Description and Business Overview
Table 100. Celgene Nanopharmaceuticals Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 101. Celgene Nanopharmaceuticals Product
Table 102. Celgene Recent Developments/Updates
Table 103. Novavax Corporation Information
Table 104. Novavax Description and Business Overview
Table 105. Novavax Nanopharmaceuticals Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 106. Novavax Nanopharmaceuticals Product
Table 107. Novavax Recent Developments/Updates
Table 108. Stryker Corporation Information
Table 109. Stryker Description and Business Overview
Table 110. Stryker Nanopharmaceuticals Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 111. Stryker Nanopharmaceuticals Product
Table 112. Stryker Recent Developments/Updates
Table 113. Gilead Sciences Corporation Information
Table 114. Gilead Sciences Description and Business Overview
Table 115. Gilead Sciences Nanopharmaceuticals Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 116. Gilead Sciences Nanopharmaceuticals Product
Table 117. Gilead Sciences Recent Developments/Updates
Table 118. OSI Pharmaceuticals Corporation Information
Table 119. OSI Pharmaceuticals Description and Business Overview
Table 120. OSI Pharmaceuticals Nanopharmaceuticals Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 121. OSI Pharmaceuticals Nanopharmaceuticals Product
Table 122. OSI Pharmaceuticals Recent Developments/Updates
Table 123. Kadmon Pharmaceuticals Corporation Information
Table 124. Kadmon Pharmaceuticals Description and Business Overview
Table 125. Kadmon Pharmaceuticals Nanopharmaceuticals Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 126. Kadmon Pharmaceuticals Nanopharmaceuticals Product
Table 127. Kadmon Pharmaceuticals Recent Developments/Updates
Table 128. Samyang Biopharm Corporation Information
Table 129. Samyang Biopharm Description and Business Overview
Table 130. Samyang Biopharm Nanopharmaceuticals Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 131. Samyang Biopharm Nanopharmaceuticals Product
Table 132. Samyang Biopharm Recent Developments/Updates
Table 133. Mitsubishi Pharma Corporation Information
Table 134. Mitsubishi Pharma Description and Business Overview
Table 135. Mitsubishi Pharma Nanopharmaceuticals Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 136. Mitsubishi Pharma Nanopharmaceuticals Product
Table 137. Mitsubishi Pharma Recent Developments/Updates
Table 138. Kaken Pharmaceutical Corporation Information
Table 139. Kaken Pharmaceutical Description and Business Overview
Table 140. Kaken Pharmaceutical Nanopharmaceuticals Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 141. Kaken Pharmaceutical Nanopharmaceuticals Product
Table 142. Kaken Pharmaceutical Recent Developments/Updates
Table 143. Selecta Biosciences Corporation Information
Table 144. Selecta Biosciences Description and Business Overview
Table 145. Selecta Biosciences Nanopharmaceuticals Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 146. Selecta Biosciences Nanopharmaceuticals Product
Table 147. Selecta Biosciences Recent Developments/Updates
Table 148. Par Pharmaceutical Corporation Information
Table 149. Par Pharmaceutical Description and Business Overview
Table 150. Par Pharmaceutical Nanopharmaceuticals Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 151. Par Pharmaceutical Nanopharmaceuticals Product
Table 152. Par Pharmaceutical Recent Developments/Updates
Table 153. Cerulean Pharma Corporation Information
Table 154. Cerulean Pharma Description and Business Overview
Table 155. Cerulean Pharma Nanopharmaceuticals Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 156. Cerulean Pharma Nanopharmaceuticals Product
Table 157. Cerulean Pharma Recent Developments/Updates
Table 158. Navidea Biopharmaceuticals Corporation Information
Table 159. Navidea Biopharmaceuticals Description and Business Overview
Table 160. Navidea Biopharmaceuticals Nanopharmaceuticals Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 161. Navidea Biopharmaceuticals Nanopharmaceuticals Product
Table 162. Navidea Biopharmaceuticals Recent Developments/Updates
Table 163. Lummy Corporation Information
Table 164. Lummy Description and Business Overview
Table 165. Lummy Nanopharmaceuticals Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 166. Lummy Nanopharmaceuticals Product
Table 167. Lummy Recent Developments/Updates
Table 168. Production Base and Market Concentration Rate of Raw Material
Table 169. Key Suppliers of Raw Materials
Table 170. Nanopharmaceuticals Distributors List
Table 171. Nanopharmaceuticals Customers List
Table 172. Nanopharmaceuticals Market Trends
Table 173. Nanopharmaceuticals Growth Drivers
Table 174. Nanopharmaceuticals Market Challenges
Table 175. Nanopharmaceuticals Market Restraints
Table 176. Global Nanopharmaceuticals Sales Forecast by Type (2022-2027) & (K MT)
Table 177. Global Nanopharmaceuticals Sales Market Share Forecast by Type (2022-2027)
Table 178. Global Nanopharmaceuticals Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 179. Global Nanopharmaceuticals Revenue Market Share Forecast by Type (2022-2027)
Table 180. Global Nanopharmaceuticals Sales Forecast by Application (2022-2027) & (K MT)
Table 181. Global Nanopharmaceuticals Sales Market Share Forecast by Application (2022-2027)
Table 182. Global Nanopharmaceuticals Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 183. Global Nanopharmaceuticals Revenue Market Share Forecast by Application (2022-2027)
Table 184. Global Nanopharmaceuticals Sales Forecast by Region (2022-2027) & (K MT)
Table 185. Global Nanopharmaceuticals Sales Market Share Forecast by Region (2022-2027)
Table 186. Global Nanopharmaceuticals Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 187. Global Nanopharmaceuticals Revenue Market Share Forecast by Region (2022-2027)
Table 188. Research Programs/Design for This Report
Table 189. Key Data Information from Secondary Sources
Table 190. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Nanopharmaceuticals
Figure 2. Global Nanopharmaceuticals Market Share by Type in 2020 & 2027
Figure 3. Liposomes Product Picture
Figure 4. Polymeric Micelles Product Picture
Figure 5. Solid Lipid Nanoparticles Product Picture
Figure 6. Microemulsion and Nnanoemulsion Product Picture
Figure 7. Nanosuspension Product Picture
Figure 8. Global Nanopharmaceuticals Market Share by Application in 2020 & 2027
Figure 9. Cancer and Tumor
Figure 10. Autoimmune Disorders
Figure 11. Inflammation
Figure 12. Others
Figure 13. Global Nanopharmaceuticals Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Nanopharmaceuticals Market Size 2016-2027 (US$ Million)
Figure 15. Global Nanopharmaceuticals Sales 2016-2027 (K MT)
Figure 16. Global Nanopharmaceuticals Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 17. Nanopharmaceuticals Sales Share by Manufacturers in 2020
Figure 18. Global Nanopharmaceuticals Revenue Share by Manufacturers in 2020
Figure 19. The Global 5 and 10 Largest Nanopharmaceuticals Players: Market Share by Revenue in 2020
Figure 20. Nanopharmaceuticals Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 21. Global Nanopharmaceuticals Sales Market Share by Region (2016-2021)
Figure 22. Global Nanopharmaceuticals Sales Market Share by Region in 2020
Figure 23. Global Nanopharmaceuticals Revenue Market Share by Region (2016-2021)
Figure 24. Global Nanopharmaceuticals Revenue Market Share by Region in 2020
Figure 25. U.S. Nanopharmaceuticals Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. Canada Nanopharmaceuticals Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. Germany Nanopharmaceuticals Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. France Nanopharmaceuticals Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. U.K. Nanopharmaceuticals Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. Italy Nanopharmaceuticals Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. Russia Nanopharmaceuticals Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. China Nanopharmaceuticals Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Japan Nanopharmaceuticals Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. South Korea Nanopharmaceuticals Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. India Nanopharmaceuticals Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Australia Nanopharmaceuticals Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Taiwan Nanopharmaceuticals Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Indonesia Nanopharmaceuticals Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Thailand Nanopharmaceuticals Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Malaysia Nanopharmaceuticals Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Philippines Nanopharmaceuticals Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Vietnam Nanopharmaceuticals Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Mexico Nanopharmaceuticals Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Brazil Nanopharmaceuticals Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Argentina Nanopharmaceuticals Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. Turkey Nanopharmaceuticals Revenue Growth Rate (2016-2021) (US$ Million)
Figure 47. Saudi Arabia Nanopharmaceuticals Revenue Growth Rate (2016-2021) (US$ Million)
Figure 48. U.A.E Nanopharmaceuticals Revenue Growth Rate (2016-2021) (US$ Million)
Figure 49. Sales Market Share of Nanopharmaceuticals by Type (2016-2021)
Figure 50. Sales Market Share of Nanopharmaceuticals by Application (2016-2021)
Figure 51. Sales Market Share of Nanopharmaceuticals by Application in 2020
Figure 52. Revenue Share of Nanopharmaceuticals by Application (2016-2021)
Figure 53. Revenue Share of Nanopharmaceuticals by Application in 2020
Figure 54. Manufacturing Cost Structure of Nanopharmaceuticals
Figure 55. Manufacturing Process Analysis of Nanopharmaceuticals
Figure 56. Nanopharmaceuticals Industrial Chain Analysis
Figure 57. Channels of Distribution
Figure 58. Distributors Profiles
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Merck Pfizer Novartis Abbott GlaxoSmithKline Roche Sanofi Eli Lilly Astrazeneca Johnson & Johnson Celgene Novavax Stryker Gilead Sciences OSI Pharmaceuticals Kadmon Pharmaceuticals Samyang Biopharm Mitsubishi Pharma Kaken Pharmaceutical Selecta Biosciences Par Pharmaceutical Cerulean Pharma Navidea Biopharmaceuticals Lummy